Adaptive Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	77.58	70.5	47.92	65.06	90.03	139.07
Short-Term Investments	140.75	156.49	174.37	281.34	408.17	214
Cash & Short-Term Investments	218.33	226.98	222.29	346.4	498.2	353.06
Cash Growth	12.88%	2.11%	-35.83%	-30.47%	41.11%	-48.70%
Accounts Receivable	48.32	50.37	41.73	37.97	40.06	17.41
Inventory	11.21	9.82	8.44	14.45	14.45	19.26
Other Current Assets	13.95	13.02	11.29	11.37	9.44	13.02
Total Current Assets	291.81	300.19	283.75	410.19	562.15	402.75
Net Property, Plant & Equipment	71.02	74.72	94.38	120.32	164.21	172.94
Other Intangible Assets	1.31	1.73	3.43	5.13	6.83	8.53
Goodwill	118.97	118.97	118.97	118.97	118.97	118.97
Long-Term Investments	18.89	13.23	33.66	-	-	217.15
Other Long-Term Assets	3.95	3.9	5.18	6.52	4.46	3.01
Total Assets	505.94	512.74	539.38	661.13	856.62	923.34
Accounts Payable	9.62	6.47	7.27	7.72	8.08	3.31
Accrued Expenses	13.68	24.69	24	22.28	28.36	24.99
Current Portion of Leases	8.51	8.92	10.24	9.38	9.23	5.06
Unearned Revenue	49.4	45.19	55.69	48.63	64.12	80.46
Other Current Liabilities	5.8	4.64	0.87	-	-	-
Total Current Liabilities	87.01	89.92	98.05	88.02	109.79	113.81
Long-Term Leases	69.12	70.23	79.15	89.39	98.77	106.69
Other Long-Term Liabilities	125.56	127.57	159.67	175.45	183.96	98.75
Total Long-Term Liabilities	194.67	197.8	238.82	264.84	282.73	205.44
Total Liabilities	281.7	287.74	336.89	352.86	392.52	319.24
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,600	1,582	1,506	1,453	1,387	1,324
Accumulated Other Comprehensive Income	-0.03	0.25	0.17	0.22	-4.12	-1.14
Retained Earnings	-1,383	-1,363	-1,304	-1,144	-919.08	-718.89
Total Common Shareholders' Equity	216.34	218.79	202.71	308.4	464.17	603.99
Minority Interest	7.9	6.21	-0.22	-0.12	-0.07	0.11
Shareholders' Equity	224.24	225	202.49	308.28	464.1	604.1
Total Liabilities & Equity	505.94	512.74	539.38	661.13	856.62	923.34
Total Debt	77.63	79.15	89.39	98.77	108	111.74
Net Cash (Debt)	140.71	147.83	132.91	247.63	390.19	241.32
Net Cash Growth	-4.82%	11.23%	-46.33%	-36.54%	61.69%	-58.42%
Net Cash Per Share	0.90	0.97	0.90	1.72	2.74	1.72
Book Value	216.34	218.79	202.71	308.4	464.17	603.99
Book Value Per Share	1.39	1.44	1.38	2.14	3.26	4.30
Tangible Book Value	96.06	98.1	80.31	184.3	338.37	476.49
Tangible Book Value Per Share	0.62	0.65	0.55	1.28	2.37	3.39

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q